Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
Publication/Presentation Date
5-2023
Published In/Presented At
Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT).. JCO 41, 9517-9517(2023).
DOI:10.1200/JCO.2023.41.16_suppl.9517Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine, Lehigh Valley Topper Cancer Institute
Document Type
Article
COinS